0
Deep & Emerging Tech·November 20, 2026·1 min read

Novartis CEO Says US China Biotech Curbs Risk Drug Development

Share

If US curbs on biotech investment in China slow cross-border collaboration, drug development timelines and trial diversity both take a hit. Biotech operators should map which discovery, data, and manufacturing partners sit in potential policy blast radiuses.

Deep & Emerging Tech

How quantum computers built from laser-trapped atoms may correct qubit errors more easily than supercooled chips, speeding the race to a usable machine

If neutral-atom architectures really ease error correction versus supercooled chips, the bottleneck in quantum shifts from physics to algorithm and application design sooner than expected. Enterprise teams with real quantum upside — optimization, chemistry, materials — should start mapping which vendors are betting on atoms vs superconducting, because ecosystem lock-in will follow the hardware choice.

Deep & Emerging Tech

Australian Energy Officials Warned of Data Center Risk, Age Says

When Australian energy authorities call hyperscale data centers a “major structural challenge” for Victoria’s grid, it underlines that compute expansion is now constrained by power politics as much as chips. If you're planning regional DC builds or heavy AI workloads, you need a live view of local grid capacity, regulatory attitude, and potential curbs — not just cloud provider roadmaps.